T1	Participants 478 511	children and adolescents with ASD
T2	Participants 712 837	55 subjects gavetheir consent and 27 were randomized in a 1 : 1 manner (mean age 9.46+/-2.46, mean nonverbal IQ 63.3+/-23.9).
T3	Participants 838 1011	Two subjects from the active group and one subject from the placebo group discontinued the study because of either a lack of efficacy or side effects (increased irritability
